Trial intelligence / Profile preview

TCM-700C in genotype 1 chronic hepatitis C

NCT00556504Phase 2Completed

Sponsor
TCM Biotech International Corp.
Start
Jul 2007
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Compound Cordyceps TCM-700C in hepatitis C (HCV), sponsored by TCM Biotech International Corp.. Started Jul 2007; status: completed.

02

Drugs

Compound Cordyceps TCM-700C
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00556504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00556504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call